Workflow
九典制药(300705.SZ):受让取得JIJ02凝胶的药物临床试验批准通知书

Core Viewpoint - Jiutian Pharmaceutical (300705.SZ) has acquired all developed results and corresponding intellectual property rights of JIJ02 gel from Chengdu Ped Bio-Pharmaceutical Co., Ltd. for 90 million yuan, aiming to enrich its product line [1] Group 1 - The acquisition amount is 90 million yuan [1] - The acquired product is JIJ02 gel, previously known as "PD-DP-008 gel" [1] - A technology transfer contract has been signed between the two companies [1]